BFM
GCTK icon

Boston Financial Management’s GlucoTrack GCTK Stock Holding History

Boston Financial Management’s Portfolio GCTK Stock Details GCTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Hold
0
– -$6.9K – 333
2023
Q4 		– Sell
-1
Closed -$19.9K – 315
2023
Q3 		$13.8K Buy
+1
New +$27K ﹤0.01% 300
2023
Q2 		– Hold
0
– -$8.97K – 312
2023
Q1 		– Hold
0
– – – 308
2022
Q4 		– Hold
0
– – – 318
2022
Q3 		– Hold
0
– – – 299
2022
Q2 		– Hold
0
– – – 281
2022
Q1 		– Hold
0
– – – 283
2021
Q4 		– Hold
0
– – – 260

Other funds holding GCTK

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
AF
Alerus Financial Grand Forks, North Dakota $2.29B AUM 30.87% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
VCM
Virtue Capital Management Brentwood, Tennessee $749M AUM 40.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Boston Financial Management's GCTK Position: Q1 2024 in Review

Boston Financial Management held its GlucoTrack (GCTK) position steady in Q1 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #333.

Boston Financial Management first reported a position in GCTK in Q3 2023 and has held it in 1 quarter since. The position peaked at $13.8K in Q3 2023. 2 funds tracked by Wall St. Rank hold GCTK as of Q1 2024.

  • Boston Financial Management held 0 shares of GlucoTrack worth $0 as of Q1 2024.
  • Boston Financial Management left its GlucoTrack share count unchanged in Q1 2024.
  • GlucoTrack made up ﹤0.01% of Boston Financial Management's portfolio in Q1 2024, its #333 holding.
  • Boston Financial Management first reported a position in GlucoTrack in Q3 2023 and has held it in 1 quarter since.
  • Boston Financial Management's GlucoTrack position peaked at $13.8K in Q3 2023.
  • 2 funds tracked by Wall St. Rank held GlucoTrack as of Q1 2024.

Based on Boston Financial Management's 13F filing for Q1 2024, filed 10 May 2024.